Walgreens had contracted with PWNHealth early in the COVID-19 pandemic when ordering a COVID-19 test required a physician’s involvement. Walgreens used PWNHealth’s network of physicians to ...

PWNHealth, which is a subsidiary of Everlywell, a digital health company, is an independent telemedicine vendor which reviews Galleri test requests, ...

At the beginning of 2020, during the COVID-19 pandemic, ordering a COVID-19 test required a physician's involvement. Walgreens contracted with PWNHealth to use its physician network to order COVID ...

The arbitrator sided with PWNHealth, and Walgreens challenged that decision in federal court in Delaware, arguing in part that damages should have been limited to $79 million per a contractual ...

Under their contract, Walgreens used PWNHealth’s physician network to order COVID-19 tests requested from Walgreens’ website during the pandemic. But in 2022, ...

The vendor, PWNHealth, notified Grail on May 19 that an “inaccurate form letter” had been sent to roughly 400 customers from May 10 to May 18, Grail said in its statement.

PWNHealth, which does business as Everly Health Solutions, separately asked, opens new tab the judge to affirm the arbitration award, according to court filings unsealed on Tuesday. Sign up here.

Hundreds of people using the 'Galleri' test from Grail were wrongly told they might have cancer, the company said in a statement Monday.

Retail pharmacy giant Walgreen Co must pay more than $987 million to satisfy an arbitration award won by telemedicine provider PWNHealth, a federal judge in Delaware ruled on Monday.

More than 400 patients who signed up to take a pioneering oncology detection test developed by US biotech company Grail received erroneous letters last month suggesting they may have developed ...

Grail said a software glitch related to their telemedicine vendor, PWNHealth, caused them to send letters to about 400 patients saying they might have cancer when they do not.